NO20003640L - New dosage form - Google Patents

New dosage form

Info

Publication number
NO20003640L
NO20003640L NO20003640A NO20003640A NO20003640L NO 20003640 L NO20003640 L NO 20003640L NO 20003640 A NO20003640 A NO 20003640A NO 20003640 A NO20003640 A NO 20003640A NO 20003640 L NO20003640 L NO 20003640L
Authority
NO
Norway
Prior art keywords
administered
dosage unit
food
outer coating
pharmaceutical
Prior art date
Application number
NO20003640A
Other languages
Norwegian (no)
Other versions
NO20003640D0 (en
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
West Pharmaceutical Service Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharmaceutical Service Dr filed Critical West Pharmaceutical Service Dr
Publication of NO20003640D0 publication Critical patent/NO20003640D0/en
Publication of NO20003640L publication Critical patent/NO20003640L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Dose-enhet med størrelse større enn 7 mm, som kan administreres oralt, omfattende et medikament og et ytre belegg som er utformet for å hindre frigivelse av medika- mentet i magen eller tynn-tarmen når den farmasøytiske dose-enheten er i nærvær av mat. Foreliggende oppfinnelse framskaffer videre en dose-enhet med størrelse større enn 7 mm, som kan administreres oralt, omfattende et medika- ment og et ytre belegg, hvor belegget er laget av et materiale som er løselig ved pH-verdier under 5,0 og egnet for å skille den farmasøytiske dose-enheten fra sam- administrert mat. Den farmasøytiske dose-enheten er fortrinnsvis i form av en belagt tablett eller kapsel. Det er fordelaktig om det ytre belegget er en polymer. I tillegg angår foreliggende oppfinnelse en framgangsmåte for å separere oralt administrerte dose-enheter fra sam- administrert mat, og bruk av nevnte farmasøytiske dose- enheter innen medisin.Dosage unit larger than 7 mm, which may be administered orally, comprising a drug and an outer coating designed to prevent release of the drug into the stomach or small intestine when the pharmaceutical dosage unit is in the presence of food. . The present invention further provides a dosage unit of size greater than 7 mm, which can be administered orally, comprising a medicament and an outer coating, wherein the coating is made of a material which is soluble at pH values below 5.0 and suitable to separate the pharmaceutical dose unit from co-administered food. The pharmaceutical dosage unit is preferably in the form of a coated tablet or capsule. It is advantageous if the outer coating is a polymer. In addition, the present invention relates to a method of separating orally administered dosage units from co-administered food, and the use of said pharmaceutical dosage units in medicine.

NO20003640A 1998-01-22 2000-07-14 New dosage form NO20003640L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form
PCT/GB1999/000193 WO1999037290A1 (en) 1998-01-22 1999-01-20 Novel dosage form

Publications (2)

Publication Number Publication Date
NO20003640D0 NO20003640D0 (en) 2000-07-14
NO20003640L true NO20003640L (en) 2000-09-12

Family

ID=10825713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003640A NO20003640L (en) 1998-01-22 2000-07-14 New dosage form

Country Status (9)

Country Link
EP (1) EP1059918A1 (en)
JP (1) JP2002501016A (en)
AR (1) AR014467A1 (en)
AU (1) AU2176099A (en)
CA (1) CA2318257A1 (en)
GB (1) GB9801363D0 (en)
NO (1) NO20003640L (en)
WO (1) WO1999037290A1 (en)
ZA (1) ZA99454B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
WO2006020009A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Solid oral dosage form of a bisphosphonate containing a chelating agent
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
CN105468895A (en) 2006-05-02 2016-04-06 普罗透斯数字保健公司 Patient customized therapeutic regimens
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
EP2069004A4 (en) 2006-11-20 2014-07-09 Proteus Digital Health Inc Active signal processing personal health signal receivers
CA2676407A1 (en) 2007-02-01 2008-08-07 Proteus Biomedical, Inc. Ingestible event marker systems
EP3236524A1 (en) 2007-02-14 2017-10-25 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
WO2008112577A1 (en) 2007-03-09 2008-09-18 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
PT2192946T (en) 2007-09-25 2022-11-17 Otsuka Pharma Co Ltd In-body device with virtual dipole signal amplification
WO2009070773A1 (en) 2007-11-27 2009-06-04 Proteus Biomedical, Inc. Transbody communication systems employing communication channels
JP2011513865A (en) 2008-03-05 2011-04-28 プロテウス バイオメディカル インコーポレイテッド Multi-mode communication ingestible event marker and system and method of using the same
KR101615128B1 (en) 2008-07-08 2016-04-26 프로테우스 디지털 헬스, 인코포레이티드 Ingestible event marker data framework
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
JP2012514799A (en) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド Methods and systems for ingestion related biofeedback and individual pharmacotherapy
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
SG10201810784SA (en) 2009-04-28 2018-12-28 Proteus Digital Health Inc Highly Reliable Ingestible Event Markers And Methods For Using The Same
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
MX2012011693A (en) 2010-04-07 2013-02-15 Proteus Digital Health Inc Miniature ingestible device.
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
WO2012071280A2 (en) 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Ingestible device with pharmaceutical product
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
BR112014001397A2 (en) 2011-07-21 2017-02-21 Proteus Biomedical Inc device, system and method of mobile communication
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
KR20150038038A (en) 2012-07-23 2015-04-08 프로테우스 디지털 헬스, 인코포레이티드 Techniques for manufacturing ingestible event markers comprising an ingestible component
DK2910013T3 (en) 2012-10-18 2018-08-06 Proteus Digital Health Inc Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device
TWI659994B (en) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 Highly-swellable polymeric films and compositions comprising the same
WO2014144738A1 (en) 2013-03-15 2014-09-18 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
CN109843149B (en) 2016-07-22 2020-07-07 普罗秋斯数字健康公司 Electromagnetic sensing and detection of ingestible event markers
KR102605670B1 (en) 2016-10-26 2023-11-24 오츠카 세이야쿠 가부시키가이샤 Methods for manufacturing capsules with ingestible event markers
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN109453166B (en) * 2018-10-16 2021-03-12 丹诺医药(苏州)有限公司 Solid dispersion of rifamycin-quinolizinone coupled molecules and application thereof
CN110613697A (en) * 2019-10-30 2019-12-27 长春迪瑞制药有限公司 Cefalexin capsule and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
FR2618331B1 (en) * 1987-07-23 1991-10-04 Synthelabo PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF UREMIA
NZ228557A (en) * 1988-04-05 1990-11-27 Kyowa Hakko Kogyo Kk Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions

Also Published As

Publication number Publication date
AR014467A1 (en) 2001-02-28
ZA99454B (en) 2000-10-23
JP2002501016A (en) 2002-01-15
AU2176099A (en) 1999-08-09
NO20003640D0 (en) 2000-07-14
CA2318257A1 (en) 1999-07-29
WO1999037290A1 (en) 1999-07-29
EP1059918A1 (en) 2000-12-20
GB9801363D0 (en) 1998-03-18

Similar Documents

Publication Publication Date Title
AR014467A1 (en) ORMALLY ADMINISTRABLE PHARMACEUTICAL DOSE UNIT OF A SIZE HIGHER THAN 7 MM THAT INCLUDES A DRUG AND EXTERNAL COATING, A METHOD TO PARASEPAR AN ORALLY ADMINISTRABLE PHARMACEUTICAL DOSE UNIT FROM A DIFFERENT CO-ADMINISTRATED FOOD AND USE COVER
EP1595538A3 (en) Modified release tamsulosin tablets
CA2144094A1 (en) Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
JP3633936B2 (en) Senna dosage form
AU4334700A (en) Pharmaceutical dosage form for pulsatile delivery of methylphenidate
BG104317A (en) Method for the treatment of capsules and dry, powder pharmaceutical forms
MX9500885A (en) Pharmaceutical preparation for oral administration.
CA2181502A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
IL211075A (en) Multiparticulate modified release composition
CA2601289A1 (en) Once-a-day oxycodone formulations
JP2006016395A (en) Pharmaceutical formulation for safe administration of drug used for treatment of drug dependency and method for obtaining pharmaceutical formulation
CA2383250A1 (en) Phytochemicals for treatment of mastalgia and endometriosis
TWI241195B (en) Preventive agent for bile acidic diarrhea
AR018582A1 (en) DOSAGE FORM IN TABLET TO ADMINISTER AN ANTAGONIST OF THE LEUCOTRIEN RECEPTORS AND THEIR USE IN THE PREPARATION OF MEDICINES
EP1217992A1 (en) Coated solid dosage forms
Namdev et al. Floating Drug Delivery Systems: An emerging trend for the treatment of peptic ulcer
SA520411808B1 (en) Deferiprone delayed-release tablets and methods for their use
JPH0624959A (en) Gastric floating type sustained release solid formulation
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
KR900015724A (en) Maveline capacity form
DK165123B (en) PROCEDURE FOR MECHANICAL WORKING OF COBALT-CONTAINING METALS AND WATER MIXABLE CONCENTRATE FOR USE IN THE PROCEDURE
US5082665A (en) Anti-snoring formulations using yohimbine
WO2007086079A3 (en) Sustained release dosage form of phenothiazine derivatives containing channelizer
RU2000114174A (en) APPLICATION OF PHOSPHOLIPID COMPLEXES OF EXTRACTS FROM VITIS VINIFERA AS ANTIATHEROSCLEROTIC AGENTS
PL1643999T3 (en) Pyridoxamine for use in the treatment of diabetic neprhopathy in type ii diabetes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application